|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-1-17
|
|
pubmed:abstractText |
To assess the clinical usefulness of published guidelines for the use of orlistat, by studying whether weight loss >/=2.5 kg during a 4 week dietary lead-in period, and weight losses of >/=5% after 12 weeks and >/=10% after 6 months of drug therapy predict weight loss and risk factor changes after 2 years.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0307-0565
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
103-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12532161-Adult,
pubmed-meshheading:12532161-Aged,
pubmed-meshheading:12532161-Anti-Obesity Agents,
pubmed-meshheading:12532161-Body Mass Index,
pubmed-meshheading:12532161-Evidence-Based Medicine,
pubmed-meshheading:12532161-Female,
pubmed-meshheading:12532161-Humans,
pubmed-meshheading:12532161-Lactones,
pubmed-meshheading:12532161-Male,
pubmed-meshheading:12532161-Middle Aged,
pubmed-meshheading:12532161-Obesity,
pubmed-meshheading:12532161-Practice Guidelines as Topic,
pubmed-meshheading:12532161-Retrospective Studies,
pubmed-meshheading:12532161-Risk Factors,
pubmed-meshheading:12532161-Weight Loss
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines.
|
|
pubmed:affiliation |
Obesity Research Unit, Helsinki University Central Hospital, Helsinki, Finland. aila.rissanen@hus.fi
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
